Skip to content

Efficacy of Cinnamon as an Adjuvant in Reducing the Glycemic Biomarkers of Type 2 Diabetes Mellitus: A Three-Month, Randomized, Triple-Blind, Placebo-Controlled Clinical Trial.

Randomized controlled trial · J Am Nutr Assoc · 2022. Source record refreshed; an explanation has not been reviewed.

Randomized controlled trialSource: PubMed · PMID 33605836

About this paper

This page identifies the publication and its source. A checked explanation of its findings is not yet available.

Reading this record

Checking bibliographic metadata does not verify a study’s conclusions or any advice previously linked to it.

CHECK THE ORIGINAL

Publication details

Efficacy of Cinnamon as an Adjuvant in Reducing the Glycemic Biomarkers of Type 2 Diabetes Mellitus: A Three-Month, Randomized, Triple-Blind, Placebo-Controlled Clinical Trial.

Lira Neto JCG, Damasceno MMC, Ciol MA et al.
J Am Nutr Assoc · 2022

PubMed ID
33605836
Record checked

A checked publication record confirms source details. It does not verify a health claim or assess the quality of the study. Our approach.